paclitaxel has been researched along with Cancer of the Urethra in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, H; Han, H; Shi, H; Wang, F | 1 |
| Ahn, JB; Bang, SM; Kim, JH; Kim, JW; Kim, KJ; Kim, SH; Kim, YJ; Lee, JO; Lee, JS; Lee, JY; Lee, KW; Ock, CY; Rha, SY; Ryu, H; Suh, KJ | 1 |
| Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB | 1 |
| Banno, E; Kanno, N; Kino, S; Nagai, Y; Nishino, A; Tahara, H; Yasuda, M | 1 |
| Fujii, N; Inoue, R; Kobayashi, K; Matsumoto, H; Matsuyama, H; Nagao, K; Shimizu, K; Yamamoto, Y | 1 |
| Ito, T; Kawashima, H; Nakatani, T; Omachi, T; Tamada, S | 1 |
| Davis, R; Lance, R; Peterson, AC | 1 |
| Ando, M; Fujimoto, H; Fujiwara, Y; Katsumata, N; Komiyama, M; Kouno, T; Matsumoto, K; Matsuoka, N; Okajima, E; Shimizu, C; Yonemori, K | 1 |
| von der Maase, H | 1 |
| Dillman, RO; Sheehy, PF; VanderMolen, LA | 1 |
1 trial(s) available for paclitaxel and Cancer of the Urethra
| Article | Year |
|---|---|
Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Paclitaxel; Patient Selection; Platinum Compounds; Survival Analysis; Survivors; Treatment Failure; Urethral Neoplasms; Urinary Bladder Neoplasms | 2007 |
9 other study(ies) available for paclitaxel and Cancer of the Urethra
| Article | Year |
|---|---|
Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ligands; Lung Neoplasms; Paclitaxel; Programmed Cell Death 1 Receptor; Urethral Neoplasms | 2022 |
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression; Gene Expression Profiling; Humans; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Transcriptome; Urethral Neoplasms | 2018 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion | 2015 |
[A CASE OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER WITH SQUAMOUS DIFFERENTIATION RESPONDING TO PACLITAXEL AND CARBOPLATIN NEOADJUVANT CHEMOTHERAPY].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Fatal Outcome; Humans; Male; Neoadjuvant Therapy; Paclitaxel; Recurrence; Tomography, X-Ray Computed; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Surgical Procedures | 2015 |
Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Paclitaxel; Prognosis; Retrospective Studies; Treatment Outcome; Urethral Neoplasms | 2016 |
[Primary urothelial carcinoma with sarcomatous transformation of the prostate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Urethral Neoplasms | 2010 |
Clear cell adenocarcinoma in a female urethral diverticulum.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Pelvic Exenteration; Radiography; Radiotherapy, Adjuvant; Urethral Neoplasms | 2003 |
Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Paclitaxel; Survival Analysis; Urethral Neoplasms; Urinary Bladder Neoplasms | 2007 |
Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Black People; California; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Urethral Neoplasms; Vinblastine; White People | 2002 |